Zoom stock jumps 11% after analyst flags ‘hidden gem’ Anthropic stake
26 January 2026
1 min read

Zoom stock jumps 11% after analyst flags ‘hidden gem’ Anthropic stake

New York, January 26, 2026, 14:58 (EST) — Regular session

Shares of Zoom Communications (ZM) climbed 10.8% to $95.08 in afternoon trading Monday, hitting an intraday high of $95.76 earlier. Despite the jump, the stock is still well below its peak levels seen during the pandemic. 1

The update came after Baird analyst William Power highlighted that Zoom’s 2023 stake in AI startup Anthropic could now be valued between $2 billion and $4 billion, depending on dilution—when new shares cut into existing ownership. Power maintained an “Outperform” rating with a $95 price target, noting that “ZM is literally invested in Anthropic’s Claude success.” 2

This matters now as investors rush to revalue software firms tied to AI, while Zoom’s main video-meetings business struggles to find steady growth post-pandemic. A venture stake that might be cashed in—or simply marked up—shifts the conversation about what the stock is “really” worth.

Zoom has had a connection with Anthropic for several years. In 2023, the company revealed it had invested in the AI startup and intended to weave Anthropic’s technology into Zoom’s products. This move fits into Zoom’s wider strategy to enhance its offerings amid competition from Microsoft Teams and other workplace platforms. 3

The company has pushed Wall Street to see AI as more than just a feature. Back in November, Zoom raised its full-year forecast, pointing to strong demand for AI tools in hybrid work setups. Valoir CEO Rebecca Wettemann noted that including Zoom’s AI Companion in paid plans might boost user adoption. 4

Zoom’s gains came as the broader market pushed higher. The S&P 500 and Nasdaq each climbed roughly 0.6% by midday, providing a stronger footing for tech stocks. 5

But the AI-stake story isn’t without complications. Valuations for private companies can fluctuate, and any fundraise or IPO down the line would probably dilute Zoom’s ownership. Plus, the stake isn’t part of Zoom’s core operations, and investors remain cautious about counting paper gains as real cash.

The next catalyst is right around the corner. Zoom is set to release earnings around Feb. 23, per Nasdaq’s calendar, with investors keen to hear about enterprise demand, paid AI features, and management’s take on their investment portfolio. 6

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings
Previous Story

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision
Next Story

Pfizer stock edges up as traders brace for Feb. 3 earnings and a Fed decision

Go toTop